28.10.2013 • News

Lonza’s Corporate Overhaul

Company

Lonza AG

Muenchensteinerstrasse 38
4002 Basel
Switzerland

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

most read

News • Strategy

Ratcliffe: Chemical Industry in Europe at a Tipping Point

Ineos CEO Ineos calls on European politicians to save the chemical industry.

News • Bioprocessing

Merck Acquires Chromatography Business from JSR Life Sciences

Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

News • Chemistry

Jens Birgersson Becomes New Brenntag CEO

Jens Birgersson becomes new Brenntag CEO

News • Chemistry

BASF Sells Majority Stake in Coatings Business

BASF sells a majority stake in its coatings business to the investor Carlyle.

News • Chemistry

Dow to Shut Down Three Upstream European Assets

Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.